471 related articles for article (PubMed ID: 28672278)
21. Novel synthesis of dihydropyrimidines for α-glucosidase inhibition to treat type 2 diabetes: in vitro biological evaluation and in silico docking.
Yar M; Bajda M; Shahzadi L; Shahzad SA; Ahmed M; Ashraf M; Alam U; Khan IU; Khan AF
Bioorg Chem; 2014 Jun; 54():96-104. PubMed ID: 24880489
[TBL] [Abstract][Full Text] [Related]
22. Exploration of aroyl/heteroaroyl iminothiazolines featuring 2,4,5-trichlorophenyl moiety as a new class of potent, selective, and in vitro efficacious glucosidase inhibitors.
Kazmi M; Zaib S; Amjad ST; Khan I; Ibrar A; Saeed A; Iqbal J
Bioorg Chem; 2017 Oct; 74():134-144. PubMed ID: 28780150
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis and docking study of novel tetracyclic oxindole derivatives as α-glucosidase inhibitors.
Han K; Li Y; Zhang Y; Teng Y; Ma Y; Wang M; Wang R; Xu W; Yao Q; Zhang Y; Qin H; Sun H; Yu P
Bioorg Med Chem Lett; 2015 Apr; 25(7):1471-5. PubMed ID: 25759031
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, biological evaluation and molecular docking study of N-arylbenzo[d]oxazol-2-amines as potential α-glucosidase inhibitors.
Wang G; Peng Z; Wang J; Li J; Li X
Bioorg Med Chem; 2016 Nov; 24(21):5374-5379. PubMed ID: 27614916
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological evaluation of novel 1,2,4-triazine derivatives bearing carbazole moiety as potent α-glucosidase inhibitors.
Wang G; Wang J; He D; Li X; Li J; Peng Z
Bioorg Med Chem Lett; 2016 Jun; 26(12):2806-2809. PubMed ID: 27177827
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of indole-based-thiadiazole derivatives as a potent inhibitor of α-glucosidase enzyme along with in silico study.
Alomari M; Taha M; Rahim F; Selvaraj M; Iqbal N; Chigurupati S; Hussain S; Uddin N; Almandil NB; Nawaz M; Khalid Farooq R; Khan KM
Bioorg Chem; 2021 Mar; 108():104638. PubMed ID: 33508679
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and biological evaluation of novel 2,4,5-triarylimidazole-1,2,3-triazole derivatives via click chemistry as α-glucosidase inhibitors.
Wang G; Peng Z; Wang J; Li J; Li X
Bioorg Med Chem Lett; 2016 Dec; 26(23):5719-5723. PubMed ID: 27810241
[TBL] [Abstract][Full Text] [Related]
28. Benzimidazole derivatives as new α-glucosidase inhibitors and in silico studies.
Zawawi NK; Taha M; Ahmat N; Wadood A; Ismail NH; Rahim F; Azam SS; Abdullah N
Bioorg Chem; 2016 Feb; 64():29-36. PubMed ID: 26637946
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory activity evaluation and mechanistic studies of tetracyclic oxindole derivatives as α-glucosidase inhibitors.
Sun H; Zhang Y; Ding W; Zhao X; Song X; Wang D; Li Y; Han K; Yang Y; Ma Y; Wang R; Wang D; Yu P
Eur J Med Chem; 2016 Nov; 123():365-378. PubMed ID: 27487567
[TBL] [Abstract][Full Text] [Related]
30. α-Glucosidase inhibition by flavonoids: an in vitro and in silico structure-activity relationship study.
Proença C; Freitas M; Ribeiro D; Oliveira EFT; Sousa JLC; Tomé SM; Ramos MJ; Silva AMS; Fernandes PA; Fernandes E
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1216-1228. PubMed ID: 28933564
[TBL] [Abstract][Full Text] [Related]
31. 3-Benzyl(phenethyl)-2-thioxobenzo[g]quinazolines as a new class of potent α-glucosidase inhibitors: synthesis and molecular docking study.
Al-Salahi R; Ahmad R; Anouar E; Iwana Nor Azman NI; Marzouk M; Abuelizz HA
Future Med Chem; 2018 Aug; 10(16):1889-1905. PubMed ID: 29882426
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, Biological Evaluation and Molecular Docking Study of 2-Substituted-4,6-Diarylpyrimidines as α-Glucosidase Inhibitors.
Gong Z; Xie Z; Qiu J; Wang G
Molecules; 2017 Oct; 22(11):. PubMed ID: 29084182
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, in vitro evaluation and molecular docking studies of novel triazine-triazole derivatives as potential α-glucosidase inhibitors.
Wang G; Peng Z; Wang J; Li X; Li J
Eur J Med Chem; 2017 Jan; 125():423-429. PubMed ID: 27689725
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of 2-indolcarbohydrazones as potent α-glucosidase inhibitors, in silico studies and DFT based stereochemical predictions.
Taha M; Ismail NH; Javaid K; Imran S; Anouar el H; Wadood A; Atia-Tul-Wahab ; Ali M; Khan KM; Saad SM; Rahim F; Choudhary MI
Bioorg Chem; 2015 Dec; 63():24-35. PubMed ID: 26398141
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, In vitro α-Glucosidase Inhibitory Potential and Molecular Docking Studies of 2-Amino-1,3,4-Oxadiazole Derivatives.
Ullah H; Rahim F; Taha M; Hussain R; Wadood A; Nawaz M; Wahab Z; Kanwal ; Khan KM
Med Chem; 2020; 16(6):724-734. PubMed ID: 31195948
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, molecular docking and α-glucosidase inhibition of 5-aryl-2-(6'-nitrobenzofuran-2'-yl)-1,3,4-oxadiazoles.
Taha M; Ismail NH; Imran S; Wadood A; Rahim F; Saad SM; Khan KM; Nasir A
Bioorg Chem; 2016 Jun; 66():117-23. PubMed ID: 27149363
[TBL] [Abstract][Full Text] [Related]
37. A new entry into the portfolio of α-glucosidase inhibitors as potent therapeutics for type 2 diabetes: Design, bioevaluation and one-pot multi-component synthesis of diamine-bridged coumarinyl oxadiazole conjugates.
Kazmi M; Zaib S; Ibrar A; Amjad ST; Shafique Z; Mehsud S; Saeed A; Iqbal J; Khan I
Bioorg Chem; 2018 Apr; 77():190-202. PubMed ID: 29421697
[TBL] [Abstract][Full Text] [Related]
38. Molecular docking studies and synthesis of novel bisbenzimidazole derivatives as inhibitors of α-glucosidase.
Özil M; Emirik M; Beldüz A; Ülker S
Bioorg Med Chem; 2016 Nov; 24(21):5103-5114. PubMed ID: 27576293
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, α-glucosidase inhibitory, cytotoxicity and docking studies of 2-aryl-7-methylbenzimidazoles.
Taha M; Ismail NH; Imran S; Mohamad MH; Wadood A; Rahim F; Saad SM; Rehman AU; Khan KM
Bioorg Chem; 2016 Apr; 65():100-9. PubMed ID: 26894559
[TBL] [Abstract][Full Text] [Related]
40. Novel pyridine-2,4,6-tricarbohydrazide derivatives: design, synthesis, characterization and in vitro biological evaluation as α- and β-glucosidase inhibitors.
Riaz S; Khan IU; Yar M; Ashraf M; Rehman TU; Shaukat A; Jamal SB; Duarte VCM; Alves MJ
Bioorg Chem; 2014 Dec; 57():148-154. PubMed ID: 25462991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
